BARCLAYS PLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$31,000
-36.7%
7,268
-21.1%
0.00%
Q2 2021$49,000
+1533.3%
9,211
+1146.4%
0.00%
Q1 2021$3,000739
+14680.0%
0.00%
Q4 2020$0
-100.0%
5
-99.9%
0.00%
Q3 2020$15,000
-59.5%
4,505
-59.3%
0.00%
Q2 2020$37,000
-19.6%
11,057
-9.7%
0.00%
Q1 2020$46,000
-67.1%
12,243
-47.3%
0.00%
Q4 2019$140,000
+6.1%
23,231
+31.7%
0.00%
Q3 2019$132,000
-84.9%
17,646
-72.7%
0.00%
-100.0%
Q2 2019$875,000
+1246.2%
64,600
+434.0%
0.00%
Q1 2019$65,000
-36.3%
12,098
-64.9%
0.00%
Q4 2018$102,000
-26.1%
34,430
+104.1%
0.00%
Q3 2018$138,000
-8.0%
16,872
+9.6%
0.00%
Q2 2018$150,000
+2.0%
15,400
-9.4%
0.00%
Q1 2018$147,000
+14.0%
16,994
+64.2%
0.00%
Q4 2017$129,000
+143.4%
10,350
+63.6%
0.00%
Q3 2017$53,000
+430.0%
6,327
+910.7%
0.00%
Q2 2017$10,000
-95.2%
626
-94.0%
0.00%
Q1 2017$209,000
+6866.7%
10,400
+2703.2%
0.00%
Q2 2016$3,0003710.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders